Brazilian Journal of Otorhinolaryngology (English Edition) Brazilian Journal of Otorhinolaryngology (English Edition)
Original article
Downregulation of Notch4 – a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma
Regulação descendente de Notch4 – um marcador prognóstico na distinção entre Carcinoma Verrucoso Oral e Carcinoma de Células Escamosas Oral
M.K. Harishankara, A. Mathan Mohanb, A. Vinod Krishnanb, Arikketh Devia,,
a SRM University, School of Bioengineering, Department of Genetic Engineering, Kattankulathur, India
b Karpaga Vinayaga Institute of Medical and Dental Sciences, Department of Oral and Maxillofacial Surgery, Oral Cancer Foundation, Kancheepuram, India
Received 20 July 2017, Accepted 26 September 2017
Abstract
Introduction

Oral verrucous carcinoma is a special form of well-differentiated squamous cell carcinoma which possesses specific clinical, morphologic and cytokinetic features that differ from other types of oral cancers and hence diagnosis requires immense experience in histopathology. Hence it is certainly important to distinguish such a lesion from other oral tumors as treatment strategies vary widely between them.

Objective

In search of a critical diagnostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma, Notch4 receptor, one of the key regulatory molecules of the Notch signaling family has been aberrantly activated in the progression of several types of tumors. However its function in oral verrucous carcinoma remains unexplored. Thus the present study aims in determining the differential expression pattern of Notch4 in oral verrucous carcinoma and oral squamous cell carcinoma.

Methods

Ten patients reported positive for oral cancer (5 patients with oral verrucous carcinoma and 5 patients with oral squamous cell carcinoma). Five normal tissue samples were also obtained and evaluated for clinicopathological parameters and immunohistochemistry, western blotting and real time polymerase chain reaction for Notch4 expression.

Results

Our results reveal that the expression of Notch4 was considerably high in oral squamous cell carcinoma lesions compared to normal tissue, whereas in oral verrucous carcinoma, irrespective of the clinicopathological features, complete regulação descendente of Notch4 was observed.

Conclusions

These preliminary findings strongly support the fact that Notch4 is downregulated in oral verrucous carcinoma and could be considered as a suitable prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma. This distinguishing marker can help in improving therapeutic options in patients diagnosed with oral verrucous carcinoma.

Resumo
Introdução

O carcinoma verrucoso de cavidade oral é uma forma especial de carcinoma de células escamosas bem diferenciado, que possui características clínicas, morfológicas e citocinéticas específicas que diferem de outros tipos de cânceres orais e, por essa razão o diagnóstico requer grande experiência em histopatologia. Portanto, é certamente importante distingui-lo de outros tumores orais, pois as respectivas estratégias de tratamento variam muito.

Objetivo

Em busca de um marcador de diagnóstico crítico na distinção entre o carcinoma verrucoso e o carcinoma de células escamosas de cavidade oral, o receptor Notch4, uma das principais moléculas reguladoras da família de sinalizadores Notch, foi ativado de maneira anormal na progressão de vários tipos de tumores. No entanto, sua função no carcinoma verrucoso permanece inexplorada. Assim, o presente estudo tem como objetivo determinar o padrão de expressão diferencial de Notch4 no carcinoma verrucoso e de células escamosas de cavidade oral.

Método

Dez pacientes tiveram resultado positivo para câncer oral (5 pacientes com carcinoma verrucoso e 5 pacientes com carcinoma de células escamosas), e, 5 amostras normais foram também obtidas. Além da avaliação dos parâmetros clínico-patológicos; foram realizados análise imunohistoquímica, Western Blot e reação de polimerase em cadeia em tempo real para a expressão de Notch4.

Resultados

Nossos resultados revelam que a expressão de Notch4 foi consideravelmente alta em carcinomas de células escamosas em comparação com os tecidos normais, enquanto que no carcinoma verrucoso, independentemente das características clínico-patológicas, observou-se regulação descendente completa de Notch4.

Conclusão

Esses achados preliminares apoiam fortemente o fato de que Notch4 estava regulado para baixo no carcinoma verrucoso oral e poderia ser considerado um marcador prognóstico adequado para distinguir entre carcinoma verrucoso e carcinoma de células escamosas de cavidade oral. Esse marcador distintivo pode ajudar a melhorar as opções terapêuticas em pacientes com diagnóstico de carcinoma verrucoso oral.

Keywords
Oral verrucous carcinoma, Oral squamous cell carcinoma, Notch4, Prognostic marker
Palavras-chave
Carcinoma verrucoso oral, Carcinoma de células escamosas oral, Notch4, Marcador prognóstico
This article is only available in PDF
Introduction

Oral Verrucous Carcinoma (OVC), typically representing a rare variant of well differentiated squamous cell carcinoma is considered to be a non-invasive form of tumor with specific clinical, morphologic and cytokinetic features.1,2 In general, lymph node and distant metastasis are rare in OVC but the large size and involvement of bone structures, renders it locally aggressive if not treated properly.3 Though OVC has unique pathological characteristics, it's very challenging for the pathologist to differentiate among oral cancer subtypes because accurate diagnosis requires adequate tumor samples as well as experienced clinicians.4 Treatment of OVC still remains controversial because of their extensive nature mimicking an invasive cancer and hence identification of a critical diagnostic marker which could discriminate the components of Oral Squamous Cell Carcinoma (OSCC) from OVC is crucial to evaluate the clinical significance of OVC.5 Therefore, the need of the hour is to identify a definite marker for OVC which could be used effectively to diagnose and treat OVC.

Notch signaling pathway is one of the cell to cell communications signaling pathways that promotes a vast array of regulatory functions such as cell proliferation, differentiation and apoptosis.6 The elevated expression of the notch signaling molecules (Notch 1–4 receptors, Delta like 1, Delta like 3, Delta like 4, Jagged 1 and Jagged 2 ligands) has been considered to be one of the critical event in several malignancies.7–9 Importantly, accumulative evidence has shown that constitutive activation of Notch4 receptor, one of the key receptor molecules of the Notch signaling family has been associated with several cancer pathogenesis. However, its function as oncogene or tumor suppressor gene is cell context specific.10,11

In our previous study, we found that Notch4 plays an important role in the pathobiology of OSCC and hence this study has been targeted to analyze the expression of Notch4 among OVC and OSCC.12 To achieve this, the expression of Notch4 was analyzed on the tumor sections of OVC and OSCC with varied clinicopathological parameters. The purpose of the study was to determine the differential expression pattern of Notch4 between the major subtypes of oral cancer such that a reliable diagnostic marker could be established for the improved treatment of OVC patients.

Materials and methodsPatients sample with clinicopathological parameters

A total of 15 post-surgical oral cancer samples which includes 5 samples reported positive for OSCC and 5 samples with OVC were collected along with 5 normal oral mucosa samples from individuals who underwent surgery for benign oral and maxillofacial conditions from the Department of Oral and Maxillofacial Surgery, Karpaga Vinayaga Institute of Dental Sciences, India. All the samples were divided into two parts: one part was fixed in 10% buffered formaldehyde solution and the other part was frozen immediately and stored in −80°C until use. Information on the various clinical parameters (gender, age, site of tumor and TNM staging) were obtained from medical records. The study was approved by the Institutional Ethical Committee (490/IEC/2013).

Immunohistochemical analysis

Immunohistochemical analysis for the tumor sections were performed as previously described.12 Primary antibodies used were as follows: Notch4 (sc-8646), GAPDH (sc-47724). After incubating the samples with HRP conjugated secondary antibodies, the slides were examined under a light microscope and the results were categorized as high, moderate and mild and negative expression based on high versus low antigen expression. All the antibodies were purchased from Santa Cruz Biotechnology, USA.

Immunoblotting

Western blot analysis was performed on total proteins harvested from the tissue sections using lysis buffer. Briefly, the separated proteins were transferred to nitrocellulose membrane (Amersham Protran, GE Healthcare Life Sciences, Germany) and blocked with 3% BSA in Tris Buffered Saline with 0.1% Tween 20 (TBST) followed by overnight incubation with anti-Notch4 (sc-8646) or anti-GAPDH (sc-47724) at 4°C. The membrane was incubated with suitable horse radish peroxidase-labeled secondary antibodies at 37°C for 1h. The blots were then developed using DAB (Sigma) as per manufacturer's protocol. Densitometric analysis was performed on the blots.

RT-PCR analysis

Total RNA was isolated from frozen tissue samples using Trizol (Merck) and quantified using the Nanodrop system (Nanodrop lite spectrophotometer, Thermo Scientific). cDNA was prepared from 1μg of total RNA using M-MuLV reverse transcriptase (New England Biolabs Inc.). Prepared cDNA was subsequently subjected to PCR amplification using the following primers: Notch4: forward: 5′-CCACTAGGCGAGGACAGCATT-3′; reverse: 5′-CAACTCCATCCTCATCAACTTCTG-3′; β actin: forward: 5′-AGAGCTACGAGCTGCCTGAC-3′; reverse: 5′-GGATGCCACAGGACTCCA-3′. The amplified PCR products were visualized using agarose gel electrophoresis by ethidium bromide staining. All the samples were normalized with β actin using densitometric analysis.

Statistical analysis

Statistical analysis of the expression of Notch4 between OVC and OSCC patients were analyzed by Student's t-test using the Graph pad online software (www.graphpad.com/quickcalcs/ttest1). All the experiments were repeated thrice and the statistical tests were performed at a significant level of p<0.05.

Results

The clinical characteristics of the OVC and OSCC patients have been summarized in Table 1. The mean age of the OVC and OSCC groups were 65.2±3.05 years and 63.8±5.19 years, respectively. Male to female ratio for both the groups was 4:1 and the primary site of the tumors was confined to buccal mucosa (3/5 in both the groups). Thus, all the major clinical parameters for both the groups selected for the study were almost identical. Although the etiological factors of OVC still remains controversial, in our study all the patients were reported with history of tobacco usage (data not shown). On performing immunolocalization for Notch4 on tumor sections it was visualized that the protein was membranous and cytoplasmic and its expression was certainly high in OSCC tumors compared to that of the normal mucosa whereas very low expression was observed in all the samples of OVC irrespective of the clinical parameters (Fig. 1). In addition, western blotting and RT-PCR data also showed that Notch4 was abundantly present in OSCC while very poor expression was seen in OVC cases (Fig. 2). Further, the densitometric analysis of the blots confirmed that Notch4 was significantly downregulated in OVC suggesting its importance in the prognosis of the tumor subtypes (Fig. 3).

Table 1.

Clinical parameters of subtypes of oral cancer (OVC and OSCC) with the expression of Notch4 represented as high, moderate, mild and negative expression based on the intensity of the proteins visualized by immunolocalization experiments (p<0.05 was considered statistically significant).

Sample no  Age (years)  Sex  Primary site of tumor  Clinical diagnosis  Notch4 expression  p-Value 
OVC 1  61  Male  Buccal mucosa  Verrucous carcinoma  Mild   
OVC 2  70  Male  Alveolar mucosa  Verrucous carcinoma  Mild   
OVC 3  64  Male  Buccal mucosa  Verrucous carcinoma  Negative   
OVC 4  57  Male  Palate  Verrucous carcinoma  Mild   
OVC 5  72  Female  Buccal mucosa  Verrucous carcinoma  Negative  0.003 
OSCC 1  68  Female  Buccal mucosa  Squamous cell carcinoma  High   
OSCC 2  70  Male  Alveolar mucosa  Squamous cell carcinoma  Moderate   
OSCC 3  52  Male  Buccal mucosa  Squamous cell carcinoma  Moderate   
OSCC 4  49  Male  Ca-Tongue  Squamous cell carcinoma  High   
OSCC 5  80  Male  Buccal mucosa  Squamous cell carcinoma  High   
Figure 1.
(0.24MB).

Immunohistochemical expression of Notch4 protein in specimens of normal mucosa and subtypes of oral cancer (OVC and OSCC) (20× magnification). (A) Immunoreactivity of Notch4 in normal mucosa of the oral cavity. (B) Immunoreactivity of Notch4 in OVC. (C) Immunoreactivity of Notch4 in OSCC.

Figure 2.
(0.06MB).

Total proteins isolated from OVC and OSCC tissue samples were analyzed by western blotting using anti-Notch4 antibody. The blots were developed using DAB, showing a high expression of Notch4 in OSCC samples whereas very poor expression was observed in OVC samples. All the experiments were performed in triplicates and the data were further analyzed by densitometry with GAPDH serving as normalizer.

Figure 3.
(0.05MB).

RT-PCR analysis of Notch4 in different subtypes of oral cancer (OSCC and OVC) showing a downregulation of Notch4 in OVC samples. Densitometric analysis was performed using ImageJ 1.47v software and the values were normalized to β Actin (***p<0.001, Student's t-test).

Discussion

Oral verrucous carcinomas are slow-growing, exophytic, well-demarcated hyperkeratotic lesions considered to be a rare variant of squamous cell carcinomas with an occurrence rate of 2–12% among all types of oral cancer.13 However, OSCC is a very common neoplasm of the oral cavity representing almost 90% of the tumors of the oral cavity.14 In general, OSCC is considered to be a more aggressive form of tumor, often leading to metastasis which is highly uncommon in OVC. In addition, the histopathological feature of OVC remains distinct from that of other conventional carcinomas.15 Though distinct, an accurate histopathological diagnosis requires a skillful pathologist and a clinician with a sufficient biopsy sample with deep infiltrating portions of lesions.16 Hence the optimal treatment for OVC still remains controversial due to difficulties in appropriate classification of lesions and also the ability to mimic the invasive OSCC in its biologic behavior.17 However, a clear identification of the tumor subtypes is of great importance as treatment strategies greatly vary among the two groups.

Innumerable studies in the past have been performed in order to identify the active molecule involved in the pathogenesis of OVC. Mohtasham et al. (2013) performed histochemical analysis of p53, Ki-67, MMP-2, MMP-9 and showed that these proteins could be used in identifying the tumor invasive front that distinguishes OSCC from OVC.18 Similarly, several proteins such as Bcl-X Retinoblastoma (Rb) oncogene and Cyclin D1 were also found to have a differential expression in OVC.19,20 However Ogawa et al. (2004) observed no obvious differences in p53 protein expression between VC and well-differentiated SCC in proliferative activity of tumor cells.16 Hence the reliability of these protein markers is questionable due to lack of uniformity in its expression pattern among individuals.21 Thus the differential diagnosis of OVC remains difficult and requires careful examination of the tumors.

Notch signaling pathway, one of the key cell communication pathways has an important role in maintaining the balance between cell proliferation, differentiation and apoptosis.22 Apart from its role in regulating biological behavior of normal cells, members of the notch family (Notch1, Notch2, Notch3 and Notch4 receptors) has also been reported to induce several types of cancer and might be considered as a potential therapeutic target in oncology.23,24 In our previous study we demonstrated that Notch4 was upregulated in the late stages of OSCC suggesting it as a potential metastatic marker.12 However, its biological function as oncogene or tumor suppressor gene is purely based on cell context. For example, Clementz et al. (2011) and Nagamatsu et al. (2014) demonstrated independently the oncogenic role of Notch4 in promoting breast malignancy and suggested it as a potential therapeutic option in treating metastatic patients.10,25 Further Ding et al. (2010) reported the upregulation of Notch4 in Salivary Adenoid Cyctic Carcinoma (SACC) and its key role in inducing SACC metastasis.11 Similarly Notch4 has been considered as a candidate histochemical marker in identifying hepatocellular carcinoma.26 Whereas in some cancer types such as renal cell carcinoma, downregulation of Notch4 has been reported.27 Hence it's impossible to generalize the role of Notch4 in progression of cancer. Till now we know of no reports that elucidate the tissue-specific expression of Notch4 in OVC and hence the current study was designed to identify its potential role in OVC pathogenesis. Results from the present study correlated with our previous study on the fact that expression of Notch4 was high in OSCC samples. Interestingly complete downregulation of Notch4 was observed in OVC patient samples confirming the cell and disease context specific role of Notch4 within the closely related oral cancer subtypes. Together this study provides new insight in bringing out a molecular approach in differentiating OVC and OSCC.

Conclusions

In summary, this study was majorly focused on deriving a key diagnostic marker that could be more specific for OVC. Hence our findings confirm that depletion of Notch4 expression in OVC tissue samples could be considered as a valuable prognostic marker in differentiating OVC from OSCC, as OSCC lesions may not be distinguished clinically or may coexist with OVC. Although our results strongly supports the significance of Notch4 as a reliable prognostic marker for OVC still elaborate studies must be performed in order to derive the regulatory factors that triggers the downregulation of Notch4 such that a novel therapeutic approach for OVC could be attained.

Conflicts of interest

The authors declare no conflicts of interest.

References
1
D.T. Oliveira,R.V. de Moraes,J.F. Fiamengui Filho,J. Fanton Neto,G. Landman,L.P. Kowalski
Oral verrucous carcinoma: a retrospective study in Sao Paulo Region, Brazil
Clin Oral Invest, 10 (2006), pp. 205-209
2
C. Steffen
The man behind the eponym: Lauren V. Ackerman and verrucous carcinoma of Ackerman
Am J Dermatopathol, 26 (2004), pp. 334-341
3
B.B. Koch,D.K. Trask,H.T. Hoffman,L.H. Karnell,R.A. Robinson,W. Zen
National survey of head and neck verrucous carcinoma: pattern of presentation, care, and outcome
Cancer, 92 (2001), pp. 110-120
4
R. Rajendran,C.K. Sugathan,J. Augustine,D.M. Vasudevan,T. Vijayakumar
Ackerman's tumour (verrucous carcinoma) of the oral cavity: a histopathologic study of 426 cases
Singapore Dent J, 14 (1989), pp. 48-53
5
J.A. Woolgar,A. Triantafyllou
Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis
6
J.A. Harper,J.S. Yuan,J.B. Tan,I. Visan,C.J. Guidos
Notch signaling in development and disease
Clin Genet, 64 (2003), pp. 461-472
7
C. Leethanakul,V. Patel,J. Gillespie,M. Pallente,J.F. Ensley,S. Koontongkaew
Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture micro dissection and cDNA arrays
Oncogene, 19 (2000), pp. 3220-3224 http://dx.doi.org/10.1038/sj.onc.1203703
8
F.K. Rae,S.A. Stephenson,D.L. Nicol,J.A. Clements
Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display
Int J Cancer, 88 (2000), pp. 726-732
9
S. Tohda,N. Nara
Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells
Leuk Lymphoma, 42 (2001), pp. 467-472 http://dx.doi.org/10.3109/10428190109064603
10
A.G. Clementz,A. Rogowski,K. Pandya,L. Miele,C. Osipo
Notch-1 and Notch-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Breast Cancer Res, 13 (2011), pp. 63
11
L.C. Ding,L. She,D.L. Zheng,Q.L. Huang,J.F. Wang,F.F. Zheng
Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma
Oncol Rep, 24 (2010), pp. 363-368
12
M.K. Harishankar,S. Prince,A.M. Mohan,K.V. Krishnan,A. Devi
Association of Notch4 with metastasis in human oral squamous cell carcinoma
13
R.C. Jordan
Verrucous carcinoma of the mouth
J Can Dent Assoc, 61 (1995), pp. 797-801
14
J.V. Bagan,C. Scully
Recent advances in oral oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication
15
J.G. Batsakis,R. Hybels,J.D. Crissman,D.H. Rice
The pathology of head and neck tumors: verrucous carcinoma
Head Neck Surg, 5 (1982), pp. 29-38
16
A. Ogawa,Y. Fukuta,T. Nakajima,S.M. Kanno,A. Obara,K. Nakamura
Treatment results of oral verrucous carcinoma and its biological behavior
17
J.E. Medina,W. Dichtel,M.A. Luna
Verrucous-squamous carcinomas of the oral cavity: a clinicopathologic study of 104 cases
Arch Otolaryngol, 110 (1984), pp. 437-440
18
N. Mohtasham,S. Babakoohi,A. Shiva,A. Shadman,K. Kamyab-Hesari,M.T. Shakeri
Immunohistochemical study of p53, Ki-67, MMP-2 and MMP-9 expression at invasive front of squamous cell and verrucous carcinoma in oral cavity
Pathol Res Pract, 209 (2013), pp. 110-114 http://dx.doi.org/10.1016/j.prp.2012.11.002
19
P.V. Angadi,R. Krishnapillai
Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103 (2007), pp. 30-35
20
S. Prabhu,P. Shukla,M. Jose
Comparison of Bcl-X expression in oral squamous cell carcinoma and verrucous carcinoma
Eur J Cancer, 51 (2015), pp. 7
21
I.B. Gimenez-Conti,A.M. Collet,H. Lanfranchi,M.E. Itoiz,M. Luna,H.J. Xu
p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas
22
K.G. Leong,A. Karsan
Recent insights into the role of Notch signaling in tumorigenesis
23
M. Brzozowa,L. Mielan??czyk,M. Michalski,L. Malinowski,G. Kowalczyk-Ziomek,K. Helewski
Role of Notch signaling pathway in gastric cancer pathogenesis
Contemp Oncol (Pozn), 17 (2013), pp. 1-5
24
S. Stylianou,R.B. Clarke,K. Brennan
Aberrant activation of notch signaling in human breast cancer
Cancer Res, 66 (2006), pp. 1517-1525 http://dx.doi.org/10.1158/0008-5472.CAN-05-3054
25
I. Nagamatsu,H. Onishi,S. Matsushita,M. Kubo,M. Kai,A. Imaizumi
Notch4 is a potential therapeutic target for triple-negative breast cancer
Anticancer Res, 34 (2014), pp. 69-80
26
S. Ahn,J. Hyeon,C.K. Park
Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma
Hepatobiliary Pancreat Dis Int, 12 (2013), pp. 286-294
27
S. Sun,R. Du,J. Gao,X. Ning,H. Xie,X. Lin
Expression and clinical significance of Notch receptors in human renal cell carcinoma
Pathology, 41 (2009), pp. 335-341 http://dx.doi.org/10.1080/00313020902885003

Please cite this article as: Harishankar MK, Mohan AM, Krishnan AV, Devi A. Downregulation of Notch4 – a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma. Braz J Otorhinolaryngol. 2017. https://doi.org/10.1016/j.bjorl.2017.09.005

Peer Review under the responsibility of Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.

Corresponding author. (Arikketh Devi adevipradeep@gmail.com)
Copyright © 2017. Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial